VIYASH SCIENTIFIC LIMITED — Call Transcript 2025

Nov 14, 2025

==> picture [153 x 43] intentionally omitted <==

Proven Ability In Life Sciences

November 14, 2025

To,

BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East), Mumbai – 400 001 Mumbai – 400 051 Scrip code: 512529 Symbol: SEQUENT

Subject: Revised Intimation of Conference call

Dear Sir/Madam,

Further to our intimation dated November 11, 2025, regarding the conference call with Analysts/Investors, we wish to inform you that the said conference call to discuss the Company’s Q2FY26 financial results, has been rescheduled to Wednesday, November 19, 2025, at 9:00 a.m. (IST) .

The details of the said rescheduled conference call are enclosed herewith and are also available on the Company’s website under the Investors section at: www.sequent.in.

You are requested to take the same on record.

Yours faithfully,

For Sequent Scientific Limited

Vora Yoshita Digitally signed by Vora Yoshita Susmit Susmit Date: 2025.11.14 21:28:29 +05'30'

Yoshita Vora Company Secretary & Compliance Officer Encl: A/a

SeQuent Scientific Limited

Registered Office: 3rd Floor, Srivalli’s Corporate, Plot No. 290, SYN 33 34P TO 39, Guttala Begumpet, Jubilee Hills, Hyderabad - 500033, Telangana Office: 301, 3[rd] Floor, Dosti Pinnacle, Plot No. E7, Road No. 22, Wagle Industrial Estate, Thane (W), Mumbai - 400604, Maharashtra Tel No.: +91 9391139986 / 22-4111 4777 I CIN: L99999TS1985PLC196357 Website : http://www.sequent.in I Email Id : investorrelations@sequent.in

==> picture [361 x 435] intentionally omitted <==

==> picture [138 x 35] intentionally omitted <==

SeQuent Q2FY26

Earnings Conference Call 19[th] November 2025, 9:00AM

Speakers

Mr. Rajaram Narayanan, MD & CEO, Sequent Scientific Dr. Hari Babu Bodepudi, WTD & CEO, Viyash Lifesciences Mr. Saurav Bhala, Chief Financial Officer, Sequent Scientific Mr. Ramakant Singani, Chief Financial Officer, Viyash Lifesciences

Dial in For SeQuent Q2FY26 Conference call, Details: 19[th] November 2025, Time: 9:00 AM +91 22 6280 1263 Universal +91 22 7115 8213 Access DiamondPass (for early Click here registration)